Joo-Youn Lee Selected Research

Joo-Youn Lee Research Topics

Disease

10	Neoplasms (Cancer) 12/2023 - 05/2016
5	Infections 01/2021 - 03/2012
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2018
2	Bites and Stings (Sting) 12/2023 - 01/2022
2	Breast Neoplasms (Breast Cancer) 12/2023 - 07/2015
2	Stomach Neoplasms (Stomach Cancer) 12/2022 - 01/2019
2	Multiple Sclerosis 01/2018 - 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 11/2023
1	Trisomy (Trisomies) 11/2021
1	Down Syndrome (Down's Syndrome) 11/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Atherosclerosis 12/2020
1	Overnutrition 03/2020
1	Weight Loss (Weight Reduction) 03/2020
1	Fatty Liver 03/2020
1	Hepatitis B 02/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Myocardial Infarction 01/2018
1	Hemorrhage 08/2016
1	Dyspnea (Shortness of Breath) 08/2016
1	Brain Neoplasms (Brain Tumor) 05/2016
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Sepsis (Septicemia) 01/2016
1	Triple Negative Breast Neoplasms 07/2015
1	Gout 03/2015
1	Periodontitis 03/2012

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2016
3	PF-543IBA 05/2020 - 01/2018
2	InterferonsIBA 12/2023 - 01/2022
2	Interferon Type IIBA 12/2023 - 01/2022
2	CytokinesIBA 12/2023 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2021 - 05/2016
2	EnzymesIBA 01/2021 - 11/2017
2	Fingolimod Hydrochloride (FTY720)FDA Link 10/2018 - 01/2018
2	Tryptophan-tRNA LigaseIBA 01/2017 - 10/2016
1	Immunomodulating AgentsIBA 12/2023
1	pyridineIBA 12/2023
1	OximesIBA 11/2023
1	AcetylcholinesteraseIBA 11/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Dyrk KinasesIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	CholesterolIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	NAD (NADH)IBA 01/2021
1	benzocycloheptapyridineIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	SteroidsIBA 01/2021
1	Plant ExtractsIBA 12/2020
1	sphingosine kinaseIBA 05/2020
1	OxadiazolesIBA 03/2020
1	SulfonamidesIBA 02/2020
1	Nylidrin (Buphenine)FDA LinkGeneric 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2020
1	Cycloheximide (Cicloheximide)IBA 01/2019
1	gambogic acidIBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 01/2019
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2017
1	TicagrelorIBA 08/2016
1	Purinergic P2Y Receptor AntagonistsIBA 08/2016
1	KRCA-386IBA 05/2016
1	CrizotinibIBA 05/2016
1	ceritinibIBA 05/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016
1	ElementsIBA 01/2016
1	3- (3,4- dimethoxyphenyl)- N- (4- hydroxyphenethyl)acrylamideIBA 07/2015
1	AmidesIBA 07/2015
1	Xanthine OxidaseIBA 03/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2012
1	Serine (L-Serine)FDA Link 03/2012

Therapy/Procedure

5	Therapeutics 12/2023 - 07/2015
3	Immunotherapy 12/2023 - 11/2017
1	Oral Administration 12/2023
1	Intravenous Injections 01/2022
1	Punctures 01/2016
1	Ligation 01/2016